Stuart Poulton

Insider Reports History

Entity
Individual
Location
85 Wells Avenue, Newton, Massachusetts
Signature
/s/Nancy Smith as Attorney-in-Fact for Stuart Poulton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stuart Poulton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. EVP, Chief Development Officer Common Stock 352 K $466 K $1.32 Feb 28, 2024 Direct
Karyopharm Therapeutics Inc. EVP, Chief Development Officer Common 330 K $395 K $1.20 Mar 1, 2024 Direct

Insider Reports Filed by Stuart Poulton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KPTI Karyopharm Therapeutics Inc. Feb 29, 2024 2 -$26.5 K 4 Mar 4, 2024 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2024 1 $0 4 Feb 29, 2024 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Feb 15, 2024 2 -$7.78 K 4 Feb 20, 2024 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Jan 24, 2024 1 $0 4 Jan 25, 2024 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Jul 28, 2023 1 -$4.84 K 4 Aug 1, 2023 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Feb 15, 2023 3 -$18.7 K 4 Feb 17, 2023 EVP, Chief Development Officer
KPTI Karyopharm Therapeutics Inc. Aug 15, 2022 0 $0 3 Aug 19, 2022 EVP, Chief Development Officer